- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Hormone Receptor (HR) Positive Breast Cancer
Total 148829 results
-
Bukwang PharmaceuticalCompletedHealthy Adult MaleKorea, Republic of
-
Yonsei UniversityRecruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | PostmenopausalKorea, Republic of
-
Dana-Farber Cancer InstituteNovartisTerminatedMetastatic Hormone-Receptor-Positive (HR+) Breast Cancer | HER2-Negative Breast Cancer | Metastatic Epithelial Ovarian CancerUnited States
-
The Affiliated Hospital of Qingdao UniversityNot yet recruitingNeoplasms | Breast Cancer | Breast DiseasesChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityUnknownMetastatic Breast CancerChina
-
Medical University of ViennaActive, not recruitingBone Diseases, Metabolic | Bone | HypophosphatasiaAustria
-
Alliance Foundation Trials, LLC.Pfizer; Breast International Group; NSABP Foundation Inc; Austrian Breast & Colorectal... and other collaboratorsActive, not recruitingBreast CancerUnited States, Spain, Italy, Ireland, United Kingdom, Australia, Germany, Japan, Portugal, Taiwan, Canada, Israel, Netherlands, Switzerland, Belgium, Austria, Hungary, Korea, Republic of, Mexico, Poland, Sweden
-
RemeGen Co., Ltd.Recruiting
-
Tvardi Therapeutics, IncorporatedCompleted
-
Spanish Breast Cancer Research GroupPierre Fabre Laboratories; Puma Biotechnology, Inc.RecruitingHER2 Positive Breast Cancer | Hormone Receptor Positive | Early-stage Breast CancerSpain
-
Centre Hospitalier Universitaire de Saint EtienneUniversity Hospital, GenevaCompleted
-
Palleos Healthcare GmbHRoche Pharma AG; Cankado GmbH; WSG WOMEN´S HEALTHCARE STUDY GROUPCompleted
-
Hunan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.RecruitingMetastatic Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHER2-positive Breast CancerChina
-
AstraZenecaCompletedBreast Cancer | PostmenopauseGermany
-
Odonate Therapeutics, Inc.TerminatedBreast CancerKorea, Republic of, United States, Spain, Canada, Singapore, Taiwan, Australia, Belgium, Thailand, Hungary, Germany, United Kingdom, France, Ukraine, Austria, Czechia, Italy, Poland, Russian Federation
-
Novartis PharmaceuticalsRecruitingBreast CancerGermany, Italy, Belgium, Denmark, France, Spain, Finland, Hungary, Ireland, Czechia, Greece, Canada, Portugal, Slovakia, Bulgaria, Poland, Romania
-
Universiti Teknologi MaraMinistry of Higher Education MalaysiaNot yet recruitingMyocardial InfarctionMalaysia
-
Vanderbilt University Medical CenterTerminatedIdentify Normal MII-pH ParametersUnited States
-
Amsterdam UMC, location VUmcUMC UtrechtCompleted
-
University Health Network, TorontoAstraZenecaCompletedBreast Cancer | Bone MetastasesCanada
-
University Health Network, TorontoEli Lilly and CompanyActive, not recruiting
-
Sun Yat-sen UniversityRecruiting
-
Icahn School of Medicine at Mount SinaiNYU Langone Health; Weill Medical College of Cornell University; Herbert Irving...Active, not recruitingAnastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic BreastBreast Neoplasms | Breast DiseasesUnited States
-
PfizerActive, not recruiting
-
Daiichi SankyoCompletedHER2-negative Breast Cancer | HER2-low Breast Cancer | Hormone-receptor-positive Breast CancerUnited States
-
The First Affiliated Hospital of Zhengzhou UniversityRecruitingBreast Cancer | Breast Cancer FemaleChina
-
PfizerCompletedBreast CancerAustralia, India
-
Puma Biotechnology, Inc.TerminatedMetastatic Cervical Cancer | Hormone Receptor-Positive, HER2-Negative Metastatic Breast CancerSpain, Israel, United States, Serbia, France, Ireland, Italy
-
Celcuity, Inc.RecruitingBreast CancerKorea, Republic of, United States, Belgium, United Kingdom, Taiwan, France, Italy, Australia, Singapore, Argentina, Canada, India, Mexico, Czechia, Spain, Austria, Bulgaria, Germany, Hungary, Poland, Brazil, Greece, Romania
-
SynDevRx, Inc.RecruitingMetastatic Breast Cancer | HR+/HER2-negative Breast CancerUnited States
-
Samsung Medical CenterNot yet recruitingPremenopausal HR+/HER2- Metastatic Breast CancerKorea, Republic of
-
BeiGeneRecruitingBreast Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Hormone Receptor Positive Malignant Neoplasm of Breast | HER2-negative Breast Cancer | Hormone-receptor-positive Breast CancerChina
-
wang shusenRecruiting
-
Johannes Kepler University of LinzCompletedCataract | Intraocular LensAustria
-
Shandong UniversityQilu Hospital of Shandong UniversityRecruitingHigh Risk Human Papillomavirus Infection | Low Grade Squamous Intraepithelial LesionChina
-
Novartis PharmaceuticalsActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterRecruitingProstate CancerUnited States
-
Novartis PharmaceuticalsRecruiting
-
Jinming YuJiangsu HengRui Medicine Co., Ltd.UnknownMetastatic Breast Cancer | HER2-positive Breast CancerChina
-
Life Meter srlCompletedLaboratory Testing on Healthy Volunteers to Verify SpO2 and Heart Rate (HR) Accuracy of BrOxy MItaly
-
University Hospitals Cleveland Medical CenterCompleted
-
Danish Breast Cancer Cooperative GroupUnknown
-
University Hospital TuebingenUniversity Hospital Freiburg; University Hospital UlmRecruitingHormone Receptor Positive HER-2 Negative Breast CancerGermany
-
Eli Lilly and CompanyCompletedHER-2 Positive Breast Cancer | Hormone Receptor Positive Breast CancerSpain, United States, Korea, Republic of, Belgium, France, Germany, Italy, Australia, Argentina, Canada, United Kingdom, Mexico, Brazil, Greece
-
Leiden University Medical CenterThe Netherlands Cancer Institute; Borstkanker Onderzoek Groep; Comprehensive... and other collaboratorsSuspendedHER2-negative Breast Cancer | Hormone Receptor-positive Breast Cancer | Neoadjuvant Chemotherapy | Fasting Mimicking Diet | Pathological Complete Response | Objective Response RateNetherlands